CN106892921B - A method of synthesis spiral shell indenes pyrrolopyridines - Google Patents
A method of synthesis spiral shell indenes pyrrolopyridines Download PDFInfo
- Publication number
- CN106892921B CN106892921B CN201710116335.3A CN201710116335A CN106892921B CN 106892921 B CN106892921 B CN 106892921B CN 201710116335 A CN201710116335 A CN 201710116335A CN 106892921 B CN106892921 B CN 106892921B
- Authority
- CN
- China
- Prior art keywords
- synthesizing
- methyl
- spiroindenepyrrolopyridine
- reaction
- compounds according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 16
- -1 indenes pyrrolopyridines Chemical class 0.000 title abstract description 14
- 238000003786 synthesis reaction Methods 0.000 title abstract description 11
- 230000015572 biosynthetic process Effects 0.000 title abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 19
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 claims abstract description 18
- UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical compound C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 9
- 230000002194 synthesizing effect Effects 0.000 claims description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 238000005935 nucleophilic addition reaction Methods 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- 238000007259 addition reaction Methods 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 239000007859 condensation product Substances 0.000 claims description 2
- 230000018044 dehydration Effects 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 238000010898 silica gel chromatography Methods 0.000 claims description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 238000006845 Michael addition reaction Methods 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 125000005594 diketone group Chemical group 0.000 claims 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims 1
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- DZTRFRMZYKJDEC-UHFFFAOYSA-N 6h-pyrrolo[3,4-b]pyridine Chemical compound N1=CC=CC2=CNC=C21 DZTRFRMZYKJDEC-UHFFFAOYSA-N 0.000 abstract description 9
- 125000004122 cyclic group Chemical group 0.000 abstract description 4
- 238000011877 intramolecular nucleophilic addition Methods 0.000 abstract description 4
- 239000000376 reactant Substances 0.000 abstract description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 150000003233 pyrroles Chemical class 0.000 description 7
- 150000002469 indenes Chemical class 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical class O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 5
- SNWQUNCRDLUDEX-UHFFFAOYSA-N inden-1-one Chemical compound C1=CC=C2C(=O)C=CC2=C1 SNWQUNCRDLUDEX-UHFFFAOYSA-N 0.000 description 5
- VYYHRKXFEWQHDT-UHFFFAOYSA-N 1-benzyl-5-methylindole-2,3-dione Chemical compound O=C1C(=O)C2=CC(C)=CC=C2N1CC1=CC=CC=C1 VYYHRKXFEWQHDT-UHFFFAOYSA-N 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000003128 rodenticide Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- 229910052723 transition metal Inorganic materials 0.000 description 4
- 150000003624 transition metals Chemical class 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- WFFZGYRTVIPBFN-UHFFFAOYSA-N 3h-indene-1,2-dione Chemical compound C1=CC=C2C(=O)C(=O)CC2=C1 WFFZGYRTVIPBFN-UHFFFAOYSA-N 0.000 description 2
- PFWJFKBTIBAASX-UHFFFAOYSA-N 9h-indeno[2,1-b]pyridine Chemical class C1=CN=C2CC3=CC=CC=C3C2=C1 PFWJFKBTIBAASX-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 238000006452 multicomponent reaction Methods 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 150000003222 pyridines Chemical class 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GBBSUAFBMRNDJC-MRXNPFEDSA-N (5R)-zopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-MRXNPFEDSA-N 0.000 description 1
- AYJJTPLDSZAGGA-UHFFFAOYSA-N 2-ethyl-7-methyl-5-(4-methylphenyl)-1,3,4,4a,5,9b-hexahydroindeno[1,2-c]pyridine Chemical compound C1N(CC)CCC2C1C1=CC=C(C)C=C1C2C1=CC=C(C)C=C1 AYJJTPLDSZAGGA-UHFFFAOYSA-N 0.000 description 1
- VFGRNTYELNYSKJ-UHFFFAOYSA-N 6-amino-1,3-dimethylpyrimidine-2,4-dione Chemical compound CN1C(N)=CC(=O)N(C)C1=O VFGRNTYELNYSKJ-UHFFFAOYSA-N 0.000 description 1
- 102000007471 Adenosine A2A receptor Human genes 0.000 description 1
- 108010085277 Adenosine A2A receptor Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 241001133958 Calyptronoma plumeriana Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000658707 Oxandra Species 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000005909 ethyl alcohol group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- GPNOEGDZKHQDSA-UHFFFAOYSA-N indeno[1,2-b]pyridin-4-one Chemical class C1=CC=C2C3=NC=CC(=O)C3=CC2=C1 GPNOEGDZKHQDSA-UHFFFAOYSA-N 0.000 description 1
- CNAFOLPGHNAMBW-UHFFFAOYSA-N indeno[2,1-b]pyrrole Chemical compound C1=CC=CC2=CC3=NC=CC3=C21 CNAFOLPGHNAMBW-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000007144 microwave assisted synthesis reaction Methods 0.000 description 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 description 1
- 229960003702 moxifloxacin Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
- QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical compound C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 description 1
- 229960005079 pemetrexed Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 1
- 159000000018 pyrido[2,3-d]pyrimidines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- LTIAEPYUMKCFJZ-UHFFFAOYSA-N pyrimido[4,5-b]quinoline Chemical class N1=CN=CC2=CC3=CC=CC=C3N=C21 LTIAEPYUMKCFJZ-UHFFFAOYSA-N 0.000 description 1
- 150000005255 pyrrolopyridines Chemical class 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960000820 zopiclone Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A method of synthesis spiral shell indenes pyrrolopyridines belong to technical field of organic synthesis.The present invention, for reactant, by intramolecular nucleophilic addition, after generating cyclic intermediate, then is dehydrated with β-ketones with Enamino-esters, 1,3- indandione and isatin and generates spiral shell [indeno [2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] class compound.The present invention is not required to anhydrous and oxygen-free reaction condition, by intramolecular nucleophilic addition, after generating cyclic intermediate, then is dehydrated generation, and this method is efficient, easy to operate, high income and environmental-friendly.
Description
Technical field
The invention belongs to technical field of organic synthesis.
Background technique
Nitrogen-containing heterocycle compound and its derivative have extensive bioactivity, each in medicine, pesticide and life science etc.
All occupy extremely important status in a field, the synthesis of these compounds is always the research hotspot of organic synthesis field.Its
In, polycyclic azoles have a pharmaceutical activity such as antitumor, antibacterial, anti-inflammatory analgesic, such as pemetrexed, Moxifloxacin,
Contain polycyclic pyrrole structure unit in the drugs such as zopiclone.Indone in the bioactive molecules such as natural products, drug, pesticide
Class compound is also widely present, and the physiological activity outstanding such as show antitumor, anti-hypertension, antiallergy.Simultaneously ring spreads out indone
Biology equally shows a variety of biologies and pharmacological activity, and the alkaloid such as separated from manaca has indone pyridine bone
Frame, derivative is found to have phosphodiesterase activity and inhibits Adenosine A2a receptor binding capacity, for treating neurological
Property disease and the relevant disease of inflammation (Aran go, G. J.;Cortes, D.; et al., Azafluorenones from
Oxandra cf. major and biogenetic considerations [J]. Phytochemistry, 1987,26, 2093-2098).It can be seen that the synthesis of polycyclic pyrrole derivatives and indone and cyclics is by increasingly wider
General concern (Rentzea, C.; Meyer, N.; Kast, J.;et al. [P]. Ger. Offen.DE 4301426,
1994.)。
There are many synthetic method about indenopyridine derivative of existing literature report, such as 2007, Manpadi etc. with
1,3- indandione rodenticide, aniline or heterocyclic compound with amino and various aromatic acids are reactant, synthesize various polycyclic indeno pyrroles
Acridine compound (Manpadi, M.; Uglinskii, P. Y.; et al. Three-component synthesis and
anticancer evaluation of polycyclic indenopyridines lead to the discoveiy of
a novel indenoheterocycle with potent apoptosis inducing properties [J]. Org. Biomol Chem., 2007, 5, 3865-3872);2007, Tu Shujiang et al. by aromatic aldehyde, 1,3- indandione rodenticide and arone,
Indenopyridine analog derivative is prepared under the conditions of ammonium acetate is existing;The same year, they were again with the third dicyan of arlydene, thioacetic acid or 4-
Methylbenzene phenyl-sulfhydrate and the reaction of 1,3- indandione rodenticide generate indone simultaneously [1,2-b] pyridine compounds (Tu, S. J.; Jiang, B.;
et al. An efficient and expeditious microwave assisted synthesis of 4-
azafluorenones via a multi-component reaction[J]. Tetrahedron Lett, 2007, 48,
1369-1374);2012, Verma etc. was reported 6- amino -1,3- dimethyl uracil, aromatic acid, three groups of 1,3- indandione rodenticide
Divide with water as solvent, p-methyl benzenesulfonic acid is made to synthesize indenopyridine [2,3- under conditions of catalystd] pyrimidines
(Verma,J. K.; Raghuvanshi, K.; et al. An efficient one-pot three-component
synthesis of functionalized pyrimido[4,5-b]quinolines and indeno fused pyrido
[2,3-d]pyrimidines in water. [J]. Tetrahedron Lett., 2012, 53, 399-402).But this
There are some problems in a little methods, including raw materials used expensive or needs are previously prepared to varying degrees, and severe reaction conditions make
With toxic solvents, transition-metal catalyst is needed, the reaction time is longer, and yield is lower, and substrate expansion range is small etc., and cannot
For synthesizing indeno-pyrrole and pyridine compounds and their.Therefore, develop efficient, economy, greenization and substrate and expand the big indenes of range
And the synthetic method of pyrrolopyridines is significant.
Summary of the invention
Technical problem to be solved by the present invention lies in the above problem is overcome, a kind of substrate is provided and expands that range is big, raw material
It is easy to get, is easy to operate, without the simple spiral shell [indeno [2,1- of transition-metal catalyste] pyrrolo- [3,4-b] pyridine -10,3'-
The synthetic method of dihydroindolines compound.
The technical scheme is that: under the conditions of existing for the solvent and catalyst, first by isatin and 1,3- indandione exists
Carry out condensation generation under alkaline condition, then by condensation product and 3- arylamino -1- methyl-1HPyrrole-2,5-diones carry out advanced in years
Then amino in the product of addition reaction and carbonyl are carried out nucleophilic addition again by Ke Er addition reaction, then by nucleophilic addition
The product of reaction by intramolecular dehydration, finally with the mixed solvent of ethyl acetate and petroleum ether carry out silica gel column chromatography to get
Spiral shell [indeno [2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] class compound;
Reaction formula are as follows:
Wherein, R1For C1~C3Alkyl, phenyl or benzyl or C1~C4It is any in alkyl-substituted phenyl, halogenophenyl
It is a kind of;
R2For C1~C3Alkyl, any one in halogen;
R3For C1~C3Alkyl, benzyl, alkoxy carbonyl group, any one in acyl group.
The reaction mechanism is as follows by the present invention:
The present invention, for reactant, by intramolecular nucleophilic addition, generates ring with β-ketones with Enamino-esters, 1,3- indandione and isatin
After shape intermediate, then it is dehydrated and generates spiral shell [indeno [2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] class compound.
The present invention exists using the β-ketones with Enamino-esters, indandione, substitution isatin being easy to get as raw material in no transition-metal catalyst
Under, it is not required to anhydrous and oxygen-free reaction condition, by intramolecular nucleophilic addition, after generating cyclic intermediate, then is dehydrated and generates spiral shell [indeno
[2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] class compound.The synthetic method is efficient, easy to operate, yield
It is high and environmental-friendly.
Further, R of the present invention1Preferably phenyl, 4- aminomethyl phenyl, 4- methoxyphenyl, 4- halogenophenyl, 4-
Halogenophenyl, 3- aminomethyl phenyl, 2- aminomethyl phenyl, 3- methoxyphenyl, 2- methoxyphenyl, 3- halogenophenyl, 2- halogeno-benzene
Any one in base, synthetic yield is up to 60%~74%.
The R2Preferably methyl, fluorine, chlorine, any one in bromine, synthetic yield is up to 60%~70%.
The R3It is preferred that the tert-butyl that is positive, benzyl, to methoxy-benzyl, benzyloxycarbonyl group, tertbutyloxycarbonyl, phthalyl
Any one in base, p-toluenesulfonyl.Its synthetic yield is up to 60%~74%.
The solvent is preferably ethyl alcohol.Work as R1For to methyl amine benzyl, R2For methyl, R3When for benzyl, use ethyl alcohol as molten
Agent, yield is up to 72%.
The catalyst is triethylamine.Work as R1For to methyl amine benzyl, R2For chlorine, R3When for benzyl, use triethylamine as molten
Agent, yield is up to 74%.
3- arylamino -1- the methyl-1HThe mixing molar ratio of pyrrole-2,5-diones, 1,3- indandione and isatin
It is 1: 1~1.5: 1~1.5.Reaction yield is up to 60%~74% under the molar ratio.
The catalyst and 3- arylamino -1- methyl-1HThe mixing molar ratio of pyrrole-2,5-diones is 0.5~2: 1.
Reaction yield is up to 60%~74% under the molar ratio.
The temperature condition of the reaction is 50~100 DEG C.In view of preferred solvent be ethyl alcohol, then select the temperature range as
Range of reaction temperature.
It is highly preferred that reaction temperature uses 80 DEG C, the reaction time can be foreshortened to 6 hours.At this temperature, reaction efficiency is most
It is high.Temperature is excessively high, overlong time, then by-product increases;Temperature is too low, and the time is too short, then reaction is incomplete.Under the reaction condition
Its synthetic yield is up to 60%~74%.
Specific embodiment
Below with reference to embodiment, the present invention is described in more detail, but protection scope of the present invention is not limited only to these realities
Apply example.
Embodiment 1: preparation structure formula following 1', 4- dibenzyl -2,5'- dimethyl -1HSpiral shell [indenes [2,1-e] pyrroles
[3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H,4H)-tetrone:
0.1085g (0.5mmol) 3-(benzylamino is added in the flask of 5mL original bottom) -1- methyl-1HPyrroles -2,5- two
Ketone, 0.0730g (0.5mmol) indandione, 0.1085g (0.5mmol) 5- methyl-N-benzyl isatin, add 15mL ethyl alcohol,
Again plus 0.0506g (0.5mmol) triethylamine, it reacts 6 hours, after reaction evaporates solvent dense under conditions of being heated to reflux
Contracting, carrying out the processing of column Chromatographic purification using silicagel column can be obtained pure 1', 4- dibenzyl -2,5'- dimethyl -1HSpiral shell [indenes [2,
1-e] pyrroles [3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H,4H)-tetrone, separation yield 72%, structure
Characterize data is as follows:
1H NMR (400 MHz, DMSO-d 6 ) δ: 7.56 (d, J = 7.2 Hz, 2H, ArH), 7.48-7.41
(m, 5H, ArH), 7.38-7.32 (m, 5H, ArH), 7.31-7.27 (m, 2H, ArH), 7.09 (s, 1H,
ArH), 7.00 (d, J = 8.0 Hz, 1H, ArH), 6.63 (d, J = 8.0 Hz, 1H, ArH), 5.91
(brs, 2H, CH2), 4.99 (s, 2H, CH2), 2.79 (s, 3H, CH3), 2.20 (s, 3H, CH3); 13C
NMR (100 MHz, DMSO-d 6 ) δ: 189.9, 175.9, 167.1, 164.5, 158.1, 141.0, 140.3,
137.5, 136.5, 135.6, 133.7, 133.4, 132.7, 132.2, 131.1, 129.7, 129.5, 128.8,
127.9, 127.6, 127.4, 126.0, 125.6, 123.5, 122.1, 114.1, 111.3, 109.2, 50.0,
45.9, 44.0, 23.9, 21.0; IR (KBr) υ: 3062, 2936, 1766, 1711, 1650, 1602, 1550,
1495, 1454, 1418, 1382, 1341, 1309, 1283, 1186, 1069, 1032, 1012, 974, 925,
861, 805, 767, 740, 709 cm-1; MS (m/z): HRMS (ESI) C37H27N3NaO4 ([M+Na]+) theoretical value
600.1894 measured value 600.1893.
Embodiment 2: the following 5'- chloro-2-methyl -4- p-methylphenyl -1H- spiral shell [indenes [2,1- of preparation structure formulae] pyrroles
[3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H,4H)-tetrone:
In embodiment 1,3-(benzylamino used) -1- methyl-1HThe 3- of pyrrole-2,5-diones equimolar amounts
(p-methylphenyl amino) -1- methyl-1HThe replacement of pyrroles -2,5- diketone, 5- methyl-N-benzyl isatin equimolar used
The 5- chlorisatide of amount is replaced, other steps are identical as example 1, obtain 5'- chloro-2-methyl -4- p-methylphenyl -1H- spiral shell [indenes
[2,1-e] pyrroles [3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H,4H)-tetrone, separation yield 70%,
Structural characterization data are as follows:
1H NMR (600 MHz, DMSO-d 6 ) δ: 10.84 (s, 1H, NH), 7.79 (brs, 1H, ArH),
7.60 (brs, 1H, ArH), 7.56 (brs, 1H, ArH), 7.43 (d, J = 6.6 Hz, 2H, ArH),
7.29-7.26 (m, 3H, ArH), 7.15-7.12 (m, 1H, ArH), 6.89 (d, J = 8.4 Hz, 1H,
ArH), 5.52 (d, J = 7.2 Hz, 1H, ArH), 2.71 (s, 3H, CH3), 2.49 (s, 3H, CH3); 13C
NMR (100 MHz, DMSO-d 6 ) δ: 189.9, 177.2, 167.3, 163.1, 157.0, 141.1, 140.5,
140.4, 136.2, 134.7, 132.9, 132.8, 131.0, 130.3, 129.4, 126.4, 125.8, 122.1,
121.9, 112.9, 111.1, 109.6, 46.5, 23.6, 21.4; IR (KBr) υ: 3394, 3035, 1713,
1657, 1619, 1555, 1511, 1476, 1442, 1376, 1339, 1310, 1249, 1207, 1178, 1121,
1076, 1032, 1008, 974, 903, 824, 766, 739, 721 cm-1; MS (m/z): HRMS (ESI)
C29H18ClN3NaO4 ([M+Na]+) theoretical value be 530.0878, measured value 530.0868.
Embodiment 3: the following 1'- benzyl -5'- chloro-2-methyl -4- p-methylphenyl -1 of preparation structure formulaHSpiral shell [indeno [2,
1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H, 4H) tetrone:
3-(benzylamino used) -1- methyl-1HThe 3-(p-methylphenyl ammonia of pyrrole-2,5-diones equimolar amounts
Base) -1- methyl-1HThe replacement of pyrroles -2,5- diketone, the chloro- N- benzyl of 5- of 5- methyl-N-benzyl isatin equimolar amounts used
The replacement of base isatin, other steps are identical as example 1, obtain 1'- benzyl -5'- chloro-2-methyl -4- p-methylphenyl -1HSpiral shell [indeno
[2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H, 4H) tetrone, separation yield 70%,
Structural characterization data are as follows:
1H NMR (400 MHz, DMSO-d 6 ) δ: 7.83-7.81 (m, 1H, ArH), 7.73 (d, J =
2.4Hz, 1H, ArH), 7.62-7.61 (m, 1H, ArH), 7.57 (brs, 1H, ArH), 7.55 (brs, 1H,
ArH), 7.44 (d, J = 8.0 Hz, 2H, ArH), 7.38 (t, J = 8.0 Hz, 2H, ArH), 7.32-7.27
(m, 4H, ArH), 7.18-7.14 (m, 1H, ArH), 6.79 (d, J = 8.4 Hz, 1H, ArH), 5.55 (d,J = 7.6 Hz, 1H, ArH), 5.04 (s, 2H, CH2), 2.74 (s, 3H, CH3), 2.50 (s, 3H, CH3)
; 13C NMR (100 MHz, DMSO-d 6 ) δ: 190.0, 175.8, 167.3, 163.0, 157.2, 141.5,
140.7, 140.5, 136.2, 136.0, 135.3, 134.6, 133.0, 132.7, 131.1, 130.3, 129.4,
128.9, 127.7, 127.4, 127.3, 125.8, 124.7, 122.3, 122.0, 112.5, 110.8, 109.3,
46.0, 44.0, 23.7, 21.4; IR (KBr) υ: 3059, 2937, 1881, 1774, 1715, 1690, 1653,
1608, 1549, 1513, 1483, 1454, 1429, 1374, 1338, 1258, 1195, 1173, 1105, 1076,
1031, 999, 942, 898, 869, 824, 766, 743 cm-1; MS (m/z): HRMS (ESI)
C36H24ClN3NaO4 ([M+Na]+) theoretical value 620.1348, measured value 620.1340.
Embodiment 4: the following chloro- 4-(4- chlorphenyl of 1'- benzyl -5'- of preparation structure formula) -2- methyl-1 H- spiral shell [indeno
[2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H, 4H) tetrone:
3-(benzylamino used) -1- methyl-1HThe 3-(rubigan ammonia of pyrrole-2,5-diones equimolar amounts
Base) -1- methyl-1HThe replacement of pyrroles -2,5- diketone, the chloro- N- benzyl of 5- of 5- methyl-N-benzyl isatin equimolar amounts used
The replacement of base isatin, other steps are identical as example 1, obtain the chloro- 4-(4- chlorphenyl of 1'- benzyl -5'-) -2- methyl-1 H- spiral shell [indenes
And [2,1-e] pyrrolo- [3,4-b] pyridine -10,3'- indoline] -1,2', 3,9 (2H, 4H) tetrone, separation yield is
62%, structural characterization data are as follows:
1H NMR (400 MHz, DMSO-d 6 ) δ: 7.85 (brs, 1H, ArH), 7.75-7.70 (m, 3H,
ArH), 7.56 (d, J = 7.6 Hz, 2H, ArH), 7.45-7.35 (m, 3H, ArH), 7.34-7.28 (m,
4H, ArH), 7.25-7.21 (m, 1H, ArH), 6.79 (d, J = 8.4 Hz, 1H, ArH), 5.63 (d, J =
7.6 Hz, 1H, ArH), 5.04 (s, 2H, CH2), 2.74 (s, 3H, CH3); 13C NMR (100 MHz, DMSO-d 6 ) δ: 189.9, 175.7, 167.3, 163.1, 156.8, 141.5, 140.5, 136.1, 136.0, 135.5,
135.2, 133.2, 132.6, 131.7, 131.2, 129.9, 129.5, 129.4, 128.9, 127.8, 127.4,
127.3, 125.9, 122.2, 121.5, 112.6, 110.8, 109.6, 46.0, 44.0, 43.8, 23.7; IR
(KBr) υ: 3059, 2932, 1766, 1711, 1659, 1609, 1555, 1492, 1453, 1442, 1370,
1340, 1253, 1170, 1091, 1032, 1010, 896, 856, 818, 763, 741, 700 cm-1; MS (m/z): HRMS (ESI) C35H21Cl2N3NaO4 ([M+Na]+) theoretical value 640.0801, measured value 640.0792.
Show that the present invention provides one kind to pass through multi-component reaction, one-step synthesis spiral shell [indeno by the example of above-mentioned offer
[2,1-e] pyrrolo- [3,4-b] 10,3 '-indoline of pyridine -] and class compound method, there is this method raw material to be easy to get, nothing
Transition-metal catalyst, easy to operate, high income and substrate is needed to expand the big advantage of range.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710116335.3A CN106892921B (en) | 2017-03-01 | 2017-03-01 | A method of synthesis spiral shell indenes pyrrolopyridines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710116335.3A CN106892921B (en) | 2017-03-01 | 2017-03-01 | A method of synthesis spiral shell indenes pyrrolopyridines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106892921A CN106892921A (en) | 2017-06-27 |
| CN106892921B true CN106892921B (en) | 2019-04-05 |
Family
ID=59185712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710116335.3A Active CN106892921B (en) | 2017-03-01 | 2017-03-01 | A method of synthesis spiral shell indenes pyrrolopyridines |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106892921B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107311849B (en) * | 2017-07-24 | 2020-04-07 | 扬州大学 | Synthetic method of ring-bridged spiroindanone compound |
| CN107936018A (en) * | 2017-12-21 | 2018-04-20 | 扬州大学 | Spiral shell [1 pyrrolo- of acenaphthylene [3,4 b] pyridine] class compound and its synthetic method |
| CN115414356A (en) * | 2022-09-27 | 2022-12-02 | 广西科技大学 | Application of indenopyrrole derivatives in preparation of antitumor pharmaceutical composition |
-
2017
- 2017-03-01 CN CN201710116335.3A patent/CN106892921B/en active Active
Non-Patent Citations (1)
| Title |
|---|
| Chao Wang et al..Efficient synthesis of functionalized spiro[indoline-3,4 -pyrrolo[3,4-b]pyridines] via one-pot three-component reaction.《Mol Divers》.2014,第18卷809-820. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106892921A (en) | 2017-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shaabani et al. | 5-Amino-pyrazoles: potent reagents in organic and medicinal synthesis | |
| Paul et al. | Three-component synthesis of a polysubstituted pyrrole core containing heterocyclic scaffolds over magnetically separable nanocrystalline copper ferrite | |
| Zhang et al. | Solid acid-catalyzed domino cyclization reaction: regio-and diastereoselective synthesis of pyrido [2, 3-d] pyrimidine derivatives bearing three contiguous stereocenters | |
| Verniest et al. | Synthesis of substituted β-carbolines via gold (III)-catalyzed cycloisomerization of N-propargylamides | |
| JP2005518369A (en) | Imidazolidines, pyrimidines and triazines for enhancing recognition as GABA-Aα5 receptor subtype ligands | |
| CN106892921B (en) | A method of synthesis spiral shell indenes pyrrolopyridines | |
| FI95259B (en) | Process for the preparation of pharmaceutically active 7-substituted-2-amino-3,5-dihydro-4H-pyrrolo / 3,2-d / pyrimidin-4-ones | |
| CN112194634B (en) | A kind of preparation method of N-difluoromethylimidazolium sulfur (seleno) urea derivative | |
| Sroor et al. | A facile and robust approach for synthesis and structural characterization of an unprecedented ring system of 4H-pyrazolo [3, 4-f] indolizine-4, 9 (2H)-dione derivatives | |
| CN110437236A (en) | A kind of indoles -1,2- and 1,4- benzodiazepine compounds and its synthetic method | |
| Awasthi et al. | A three-component, general and practical route for diastereoselective synthesis of aza-spirocyclic pyrazolones via a decarboxylative annulation process | |
| Wang et al. | Microwave-assisted chemoselective reaction: a divergent synthesis of pyrazolopyridine derivatives with different substituted patterns | |
| Xiao et al. | Iron-Catalyzed One-Pot Synthesis of Indole-Tethered Tetrasubstituted Pyrroles and Their Transformations to Indolizino [8, 7-b] indole Derivatives | |
| Spano et al. | Convenient synthesis of pyrrolo [3, 4-g] indazole | |
| Sharma et al. | Synthesis of novel fluorinated multisubstituted pyrimidines and 1, 5-benzodiazepines via fluorinated N, S-acetals | |
| Pierce et al. | Synthesis of novel 3, 4-diaryl-5-aminopyrazoles as potential kinase inhibitors | |
| CN106977524B (en) | A kind of synthetic method of phenanthro- furans and azoles | |
| Song et al. | Facile microwave-assisted synthesis of benzimidazole scaffolds via Ugi-type three-component condensation (3CC) reactions | |
| Tang et al. | Synthesis of 8-bromo-7-chloro [1, 2, 4] triazolo [4, 3-c] pyrimidines, their ring rearrangement to [1, 5-c] analogues, and further diversification | |
| CN104710426B (en) | Benzopyrrolizidine alkaloid and its preparation method and use | |
| Zhang et al. | Synthesis and anti-proliferative activity evaluation of novel 1, 4-naphthoquinones possessing pyrido [2, 3-d] pyrimidine scaffolds | |
| Fukuda et al. | A Synthesis of Lamellarins via Regioselective Assembly of 1, 2, 3-Differentially Substituted 5, 6-Dihydropyrrolo [2, 1-a] Isoquinoline Core | |
| Tandon et al. | Synthesis of 3, 6-diaryl-1 H-pyrazolo [3, 4-b] pyridines via one-pot sequential Suzuki–Miyaura coupling | |
| Sreenivas et al. | Copper-mediated domino synthesis of pyrimido [4, 5-b] carbazolones via Ullmann N-arylation and aerobic oxidative C–H amidation | |
| Messaoudi et al. | Stepwise synthesis of 2, 6-difunctionalized ethyl pyrazolo [1, 5-a] pyrimidine-3-carboxylate via site-selective cross-coupling reactions: experimental and computational studies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |